Literature DB >> 27494676

Risk Factors for Glaucoma in a Cohort of Patients with Fuchs Heterochromic Iridocyclitis.

Jason T Toniolo1,2, Anthony J Hall1,3, Jennifer G Smith4, Jaime Levy5, Lyndell L Lim3,2.   

Abstract

PURPOSE: To describe the incidence and risk factors for ocular hypertension and/or glaucoma in patients with Fuchs heterochromic iridocyclitis (FHC).
METHODS: Retrospective analysis of 88 patients with FHC. Kaplan-Meier curves estimated the time to develop cataract and ocular hypertension/glaucoma. Possible prognostic factors were investigated in univariate Kaplan-Meier analyses using the Mantel-Cox logrank test.
RESULTS: At presentation with FHC, 52% of patients had a cataract and 26% of patients had ocular hypertension/glaucoma. The estimated percentage of patients with a cataract or ocular hypertension/glaucoma by 4 years after presentation was 71% (CI: 58-81%) and 39% (CI: 28-51%), respectively. Patients aged ≥50 years had significantly greater risk of developing glaucoma (p = 0.0065). After adjusting for age-group, having a cataract at presentation was associated with increased risk of glaucoma (p = 0.032).
CONCLUSIONS: Risk factors for development of ocular hypertension/glaucoma were increasing patient age and having a cataract at presentation with FHC.

Entities:  

Keywords:  Cataract; glaucoma; heterochromia; uveitis

Mesh:

Year:  2016        PMID: 27494676     DOI: 10.1080/09273948.2016.1199712

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

1.  Evaluation of radial peripapillary capillary density in patients with Fuchs uveitis syndrome.

Authors:  Yasin Sakir Goker; Pinar Cakar Ozdal; Yasemin Ozdamar Erol; Hasan Kızıltoprak; Mustafa Salih Karatepe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-22       Impact factor: 3.117

2.  The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.

Authors:  Ufuk Elgin; Emine Sen; Kubra Ozdemir; Pinar Ozdal; Nilufer Berker
Journal:  Int Ophthalmol       Date:  2019-12-03       Impact factor: 2.031

3.  Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.

Authors:  Hamed Esfandiari; Nils A Loewen; Kiana Hassanpour; Ali Fatourechi; Shahin Yazdani; Chao Wang; Mehdi Yaseri; Mohammad Pakravan
Journal:  F1000Res       Date:  2018-06-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.